Fig. 1

(A) The reduction in THP-1 cell viability was observed in response to increasing concentrations of AsA. The dose–response curve for THP-1 cells was generated following a 24-h treatment with different concentrations of AsA (0.125, 0.25, 0.5, 1, 2, 4, 8, 16 and 32 µg/mL). (B) The decrease in the viability of K562 cells was observed with increasing concentrations of AsA. (C) The dose–response curve of normal monocytic blood cells. The dose–response curve for normal monocytic cells was generated following a 24-h treatment with different concentrations of AsA (0.125, 0.25, 0.5, 1, 2, 4, 8, 16, and 32 µg/mL).